5-(3-Trifluoromethylphenyl)-2H-pyrazol-3-ylamine, 95.0%, 250mg

ethyl 5-[4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-5-oxovalerate, 97.0%, 1g

2-Bromo-9,9-diphenyl-9H-fluorene, 95.0%, 10g

Methyl 4-chloro-2-((2,4-dimethoxybenzyl)amino)-3-methylquinoline-6-carboxylate, 1g

TERT-BUTYL 6-METHYLIDENE-2-AZASPIRO[3.3]HEPTANE-2-CARBOXYLATE, 95.0%, 250mg

1-(3-chloro-2-methylphenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, 95.0%, 5g

Ethyl 1-Boc-5-oxoazepane-4-carboxylate, 90.0%, 25g

4-Ethynyl-2-methylpyridine, 98%, 10g

2,2'-Dinitrodibenzyl>98.0%(GC)25g

(3-Bromophenyl)-pyridin-2-ylmethanol, 95%, 500mg

2-Bromoacetamide>98.0%(GC)(N)5g

4-CHLORO-2-FLUORO-5-METHYLPHENYLSULFONYL CHLORIDE, 95.0%, 1g

Recipiente de evaporación ROTILABO® con fondo redondo, 35 ml, 10 Unidad(es)